MoneyWorks4Me

Aurobindo Pharma informs about clarification on news item

05 Mar 2018 Evaluate

Aurobindo Pharma has informed about clarification on news item appeared on www.moneycontrol.com & www.bloombergquint.com dated March 5, 2018 -‘US FDA observations - Aurobindo Unit 4 inspected by US FDA from Feb 12-20 and issues 9 observations’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..